The consequences of a delayed intervention in aTTP acute setting

September 2024 Pharma News Jolien Blokken
(sponsored)

Webinar Thursday October 24, 2024, 06:00-07:00pm CEST

Welcome and Introduction
Dr. Shruti Chaturvedi
(12:00–12:05pm EDT | 6:00–6:05pm CEST)

Efficacy and Safety of an aTTP* Therapy in a Phase III Pivotal Trial
Dr. Jamile Shammo
(12:05–12:15pm EDT | 6:05–6:15pm CEST)

A Case Study Approach for the Management of aTTP Treatment
Dr. William Aird
(12:15–12:30pm EDT | 6:15–6:30pm CEST)

Learning From the Experience: When and How to Intervene in aTTP Treatment
Dr. Yoshitaka Miyakawa
(12:30–12:45pm EDT | 6:30–6:45pm CEST)

Q&A
(12:45–1:00pm EDT | 6:45–7:00pm CEST)